Concepedia

Publication | Closed Access

Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus

DOI

235

Citations

24

References

2014

Year

Sue Sha, David Polidori, Tim Heise, Jaya Natarajan, Kristin Farrell, Shoei‐Shen Wang, Domenic Sica, Paul Rothenberg, Leona Plum‐Mörschel
Diabetes Obesity and Metabolism

Abstract

Canagliflozin provided sustained effects on UGE and FPG over 12 weeks and a transient reduction in plasma volume that was largely attenuated by week 12.

References

YearCitations

Page 1